Results 251 to 260 of about 3,116,614 (307)

Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation. [PDF]

Cell Mol Life Sci
He G, Shao W, Wang W, Sun L, Gao B, Wei J.   +5 more
europepmc   +1 more source

Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin/GPX4-Mediated Ferroptosis. [PDF]

Biomater Res
Feng W, Xu J, Chen B, Liu J, Hu Y, Cao X, Qi J, Ju L, Shao J, Dong P, Chen L, Wang F.   +11 more
europepmc   +1 more source

miR-199a-5p/GPR89A axis modulates sorafenib resistance in hepatocellular carcinoma through glutamate metabolic reprogramming. [PDF]

Sci Prog
Li Y, Cai Y, Duan G, Du Y, Hu J, Han X, Tang X, Jiang L, Ren J, Huo Q.   +9 more
europepmc   +1 more source

MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma. [PDF]

Int J Mol Sci
Leoni I, Galvani G, Monti E, Vianello C, Valenti F, Pincigher L, Grolla AA, Moro M, Coada CA, Perrone A, Righi V, Marinelli S, Ravegnini G, Giovannini C, Baldassarre M, Pariali M, Ravaioli M, Cescon M, Vasuri F, Domenicali M, Negrini M, Piscaglia F, Fato R, Stefanelli C, Gramantieri L, Bergamini C, Fornari F.   +26 more
europepmc   +1 more source

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity. [PDF]

Clin Transl Med
Wang X, Su Y, Lan B, Li X, Zhang B, Zhang L, Wang Y, Zhang C, Xuan C.   +8 more
europepmc   +1 more source

Erratum: cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence: Erratum. [PDF]

Int J Biol Sci
Ruan Y, Chen T, Zheng L, Cai J, Zhao H, Wang Y, Tao L, Xu J, Ji L, Cai X.   +9 more
europepmc   +1 more source

Exploring the potential mechanisms of sorafenib resistance in hepatocellular carcinoma cell lines based on RNA sequencing. [PDF]

Cancer Cell Int
Sun M, Zhang Z, Chen C, Zhong J, Long Z, Shen L, Huang H, Lu J.   +7 more
europepmc   +1 more source

Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression

, 2011
Liang Zhang, Manoj Bhasin, Rachel Schor-Bardach, Xiaoen Wang, Michael P. Collins, David J. Panka, Prabhakar Putheti, Sabina Signoretti, David C. Alsop, Towia A. Libermann, Michael B. Atkins, James W. Mier, S. Nahum Goldberg, Rupal S. Bhatt   +13 more
openalex   +2 more sources

DDX42 Enhances Hepatocellular Carcinoma Cell Proliferation, Radiation and Sorafenib Resistance via Regulating GRB2 RNA Maturation and Activating PI3K/AKT Pathway. [PDF]

J Cell Mol Med
Liu Z, Yuan J, Liu F, Zeng Q, Wu Z, Yang J.   +5 more
europepmc   +1 more source

Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance

, 2019
Daimin Xiang, Wen Sun, Tengfei Zhou, Cheng Zhang, Zhuo Cheng, Shichao Li, Weiqi Jiang, Ruoyu Wang, Gongbo Fu, Xiuliang Cui, Guojun Hou, Guang‐Zhi Jin, Hengyu Li, Cai-Ying Hou, Hui Liu, Hongyang Wang, Jin Ding   +16 more
openalex   +1 more source